On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

The influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally.

Discover the top CRISPR companies driving innovation in gene editing, from biotech pioneers to promising start-ups shaping the future of medicine and genetics.

Scientists are nearing a breakthrough in using CRISPR gene-editing to eliminate HIV from human DNA. Early trials of EBT-101 ...

Scientists injected a fragment of 40,000-year-old genetic material into laboratory mice, revealing skeletal changes from a ...

The Wyss team designed a CRISPR RNA therapy able to broadly fight influenza A virus infection and a preclinical system to ...

Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic ...